Physiomics (LON:PYC) Shares Down 11.2% – What’s Next?

Physiomics Plc (LON:PYC)’s share price fell 11.2% on Thursday . The company traded as low as GBX 0.44 and last traded at GBX 0.44. 871,681 shares were traded during mid-day trading, a decline of 88% from the average session volume of 6,996,127 shares. The stock had previously closed at GBX 0.50.

Physiomics Stock Down 11.2%

The firm has a market cap of £1.35 million, a P/E ratio of -2.61 and a beta of 1.69. The firm has a fifty day moving average of GBX 0.40 and a 200-day moving average of GBX 0.40.

Physiomics (LON:PYC) last issued its earnings results on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative return on equity of 89.43% and a negative net margin of 50.92%. On average, equities analysts forecast that Physiomics Plc will post -0.13 EPS for the current year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.